Company ProfilePremium

Minotaur Exploration Limited

Company Profile Analysis

Ticker: ADN.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Minotaur Exploration Limited - Company showcase

Year Founded & Workforce

2001

Minotaur Exploration Limited logo

Minotaur Exploration Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Minotaur Exploration Limited Overview

Andromeda Metals is an Adelaide-based, pre-revenue industrial and critical-minerals developer. Its anchor asset is the 100%-owned Great White Project (GWP) on South Australia's Eyre Peninsula, a high-purity kaolin deposit. GWP has a 15.1 Mt ore reserve, a 28-year mine life, granted mining and miscellaneous-purpose leases, and binding offtake covering the initial Stage 1A+ (100 ktpa). That offtake is led by the commodity merchant Traxys.

The company came to own 100% of Great White by absorbing Minotaur Exploration in 2022. Since then it has added a second leg: a proprietary process that makes 4N (≥99.99%) high-purity alumina (HPA) directly from Great White kaolin. A 2025 scoping study put this at a pre-tax NPV10 of about A$1.48 billion, and the process was validated at continuous pilot scale in August 2026.

Against this technical progress, Andromeda faces an acute funding gap. It needs about A$40 million of equity, alongside a credit-approved A$75 million Merricks Capital debt facility, to reach a final investment decision (FID). It held about A$3.2 million in cash at 30 June 2026, and its FY2026 accounts carry a going-concern material uncertainty.


What the company does

Andromeda is a single-jurisdiction (South Australia) development company with two linked value streams.

1. Refined kaolin (Great White Project).

Process: Ore is mined from ML 6532 near Poochera and wet-processed on site. Refining removes quartz and impurities to produce dried, bagged, high-brightness kaolin products.

Lead product: Great White CRM™, a ceramics-grade refined kaolin for high-end ceramics such as porcelain and sanitaryware.

Other products: Great White KCM™90 (a premium ceramics/coatings grade); Great White HRM™ (a refined halloysite-kaolin product used as a rheology modifier and as an additive to help decarbonise concrete); and industrial sand co-products.

2. High-purity alumina (HPA Project).

Process: A proprietary flowsheet makes 4N HPA directly from refined Great White kaolin. Conventional routes use aluminium metal (the alkoxide process) or smelter-grade alumina as feedstock.

End markets: LEDs, lithium-ion battery separator coatings, semiconductors and electronics, synthetic sapphire, and advanced ceramics.

By-products under evaluation: amorphous silica and gallium.

Business and revenue model

DimensionCharacterisation
Current revenueNil operating revenue (FY2022–FY2026). Barchart records about US$27k of FY2025 "sales", likely sample or incidental income
Planned revenue model100% product sales (physical minerals). No service, subscription or licensing revenue. A possible future licensing angle for the HPA process is not disclosed
Sales channelThrough a merchant/offtaker: Traxys Europe S.A. buys Great White CRM™ and HRM™ for the first 5 years (binding agreement, July 2024). Earlier direct offtake with Plantan Yamada Co Ltd for Japan (June 2023). Traxys North America is the proposed HPA route into the US (non-binding HoA, August 2026)
PricingYears 1–2 of Traxys offtake priced consistent with 2023 feasibility-study assumptions. Year 3 onward set by annual negotiation, with the audited weighted-average sales price as fallback. Upside on Traxys on-sales is shared 50/50
Value-chain positionUpstream miner/processor of industrial minerals, moving into chemical refining (HPA), a midstream critical-mineral product
Customer typesCeramics manufacturers (Europe, Japan, India/Middle East via Traxys), concrete/cement additive users, and for HPA, battery separator, LED/sapphire and semiconductor supply chains
End marketsCeramics (tiles, sanitaryware, tableware), construction (concrete), and technology/energy-transition (HPA)

Company's own description

In its June 2026 quarterly report, Andromeda describes its activity as advancing two things in parallel: the Great White Project, and its critical-mineral HPA Project, which it intends to commercialise using its proprietary process with high-quality Great White kaolin as feedstock (paraphrased, ADN Quarterly Activity Report, 31 July 2026).

In the half-year report to 31 December 2024, management stated the primary focus as advancing the Great White Project.

Independent characterisation

Andromeda is a funding-constrained, development-ready single-asset company. Its strategic narrative has shifted from a niche industrial mineral (kaolin, where demand is steady but low-growth) towards a critical mineral (HPA, higher growth and policy support).

The engineering, permitting and offtake work on GWP is largely complete. The binding constraint is capital: market value (about A$31M) is a fraction of the remaining equity requirement (about A$40M). In practice the company's equity is now an option on a funding event, most plausibly an asset-level investment from a cornerstone investor.

The roughly A$99M non-cash write-down in FY2026 is the clearest accounting sign that the carrying value of the project had diverged from what the market and funding conditions would support.

Strategy

Stated strategy (paraphrased from 2024–2026 filings)

  1. Bring GWP into production, starting with Stage 1A+ (100 ktpa). Secure the balance of funding for FID, execute the Merricks facility and resume construction.

  2. Commercialise HPA from Great White kaolin. Use the proprietary process to create a second, higher-margin critical-minerals business. Use pilot samples to secure customers, then complete a PFS.

  3. Maintain capital discipline. Implement cost savings (about A$3M identified), defer non-critical engineering, and use the R&D tax incentive.

  4. Grow the kaolin portfolio over time. Explore Eyre Kaolin JV and Mt Hope for future feed. Gold/copper exploration has been exited.

Initiatives announced in the last 24 months

DateInitiativeTarget / detailStatus
Jul 2024Binding Traxys offtake5-year CRM/HRM offtake supporting Stage 1A+In force (subject to production)
Jul 2024Eyre Kaolin JV earn-in51% earned; option to 80% for a further A$2M by November 2027Ongoing
Jun 2025Merricks Capital A$75M debt facilityCovers principal, capitalised interest, fees, reserves and a cost-overrun trancheCredit-approved; documentation subject to equity close
Sep 2025HPA Scoping Study10,000 tpa; NPV10 about A$1.48bnCompleted
Nov 2025 – Jun 2026GWP early worksAccess, earthworks, drilling, long-lead logisticsCompleted; detailed design partly on hold
2025–26Global cornerstone equity processAsset-level investment in GWP and HPA from a Middle East-based investor; due diligence completeDelayed by geopolitical events
Mar 2026Cost programmeAbout A$3M of savings across early works, procurement and administrationImplemented
Jun–Aug 2026HPA pilot plantCommissioning, then 4N at continuous scaleAchieved 24 August 2026
Aug 2026Traxys North America HPA HoAUS HPA supply pathway linked to Project VaultNon-binding
H2 2026HPA customer sampling and PFSSamples in H2 2026; PFS subject to fundingPending
2,026Assessment of "funding, strategic and corporate opportunities"Signals openness to corporate transactionsOngoing

Guidance and targets

Funding: equity balance for Stage 1A+ FID of about A$40M (indicative), excluding possible effects of recent geopolitical events on diesel pricing or availability.

Production timing: Invest SA once indicated mining in H2 2026. This is no longer realistic absent FID (analyst view).

HPA: commercial 4N samples in H2 2026.

No medium-term financial targets: (revenue, margin) have been issued. Aggregator consensus once showed a A$34M profit in 2027 (Simply Wall St, one analyst, dated 2025). Treat this as stale.

Products & Services

Great White Project (kaolin)

ProductDescriptionKey specification / capabilityTarget customerStatus / yearPricing
Great White CRM™Refined, dried, bagged ceramics-grade kaolinHigh brightness/whiteness suited to premium porcelain and sanitaryware; validated by global ceramics experts per companyEuropean, Japanese, Indian and Middle Eastern ceramics makers (via Traxys)Pre-production. Traxys contract years: 25,000 wmt year 1, 40,000 wmt year 2, then a higher base from year 3 (±10% at Traxys's option)Years 1–2 at 2023 DFS assumptions; then annual negotiation; 50/50 upside sharing
Great White KCM™90Premium refined kaolin gradeHigher-specification ceramics/coatings use; identified as a core product in H1 FY2024Specialty ceramics/coatingsPre-production; earlier offtake for 5,000 t in year 1 under prior agreements—
Great White HRM™Refined halloysite-kaolin additiveRheology modifier; additive to help decarbonise concreteConcrete and construction chemicalsTraxys: 5,000 wmt in year 1, then 10,000 wmt/yr. Some HRM offtakes conditional on market acceptance—
Industrial sand co-productsBy-product quartz sandComplementary productConstruction/industrial usersPre-production—
SourceCapex (AUD Mn)NPV (AUD Mn)IRR
Stockhead / MST Access summary194 (three stages)76343%
ADN H1 FY2024 reportNot statedAbout 1,010 pre-tax (65% improvement, 28-year life)Not stated

Project specification:

Location and tenure: ML 6532 (319 ha), MPL 163 for the water pipeline (78 ha), MPL 164 for the access road (13 ha), near Poochera on the Eyre Peninsula, South Australia.

Development stages: Stage 1A+ at 100 ktpa; Stage 1B adding 110 ktpa; Stage 2 adding 120 ktpa (total about 330 ktpa).

Mine life and reserve: 28-year life; ore reserve 15.1 Mt.

Long-lead equipment, status at 30 June 2026: - Fluid bed dryer, thickener and filter press: factory acceptance tested and stored in Australia.

  • Drum washer: factory acceptance tested and warehoused overseas.

  • Filter cake feeder: design complete; fabrication to start after FID.

Water supply: SA Water pipeline to be funded and built by Andromeda, then handed to SA Water.

Feasibility economics (2023 DFS) — conflicting figures. Two sets of numbers circulate, and the difference likely reflects pre-tax versus post-tax figures or an updated case. Not reconciled here.

Stage 1A+ funding was framed by Invest SA as A$90M, including A$84M of capex, plus financing costs.

HPA Project

ItemDetail
Product4N high-purity alumina (≥99.99% Al₂O₃), in amorphous and crystalline alpha forms
ProcessProprietary flowsheet starting directly from kaolin. HPA patent moved from the PCT phase into national phase (June 2026 quarter)
Purity achieved99.9985% at laboratory scale (2025). 99.9986% at continuous pilot scale (24 August 2026), with total metallic impurities of 14.47 ppm by GDMS, independently analysed by EAG Laboratories (Eurofins)
Scoping Study (18 September 2025)10,000 tpa 4N HPA from about 30,000 tpa kaolin; ramp of 2,500 tpa per year to full rate in year 4; 24-year life. Capex: about A$155M pre-production (about A$159M total incl. about 30% contingency); capital intensity A$15,459/t. Costs and margins: opex A$4,718/t; assumed price A$31,250/t; cash margin A$26,532/t. Value: pre-tax NPV10 about A$1.48bn; average annual EBITDA about A$247M. Emissions: 6.47 tCO₂/t HPA, 48% below the alkoxide route
Next stepsCommercial samples for customer evaluation in H2 2026; Pre-Feasibility Study (PFS) subject to funding
Co-productsAmorphous silica and gallium under evaluation
Target customersBattery separator coaters, LED/sapphire makers, semiconductor/electronics; US critical-mineral supply chain via Traxys North America (Project Vault alignment)
PricingNot publicly disclosed beyond the scoping assumption

Exploration and other assets

AssetDescriptionInterest
Eyre Kaolin JVFour ELs (Aspen, Whistler, Hotham, Thredbo) near GWP with complementary kaolin; Chairlift drill samples from 2025 still awaiting analysis51%; can earn a further 29% (to 80%) by spending A$2M by November 2027
Mt Hope Kaolin (EL 6286)Kaolin exploration100%
GWP regional ELs (Tootla, Mt Hall, Mt Cooper)Regional kaolin exploration100%
Streaky Bay Pilot PlantSample preparation and testing facility100% (asset)
Legacy Wudinna / MoontaGold/copper assets divested in 2024; small retained areasRetained portions only
Camel Lake halloysite-kaolinListed by aggregators; not in the June 2026 tenement schedule—

Financial Narrative

Source unless stated: S&P Global Market Intelligence via StockAnalysis (FY2026 income statement updated 29 September 2026; balance sheet to 31 December 2025), cross-checked with TipRanks, Barchart and Kalkine. FY2026 cash flow figures come from the ADN Appendix 5B for the quarter to 30 June 2026 (12-month year-to-date). All figures are A$M unless stated.

Income statement

Margins and growth. Gross, operating, EBITDA and net margins are not meaningful because revenue is nil. Revenue CAGR is not meaningful.

Balance sheet

Full FY2026 year-end balance sheet detail was not available in sources reviewed, so FY2021–FY2025 are shown. Interim points follow in 6.2a.

6.2a Interim and latest balance-sheet points

Restricted security: A$90k Westpac credit-card facility, secured against term deposits (A$10k drawn at 30 June 2026). Andromeda has no borrowings. The Merricks A$75M facility is credit-approved but not executed or drawn.

Cash flow

FY2026 Appendix 5B detail (12 months to 30 June 2026):

Operating: exploration and evaluation expensed -A$1.995M; administration and corporate -A$3.923M; government grants and tax incentives +A$0.644M.

Investing: PP&E -A$1.877M; capitalised E&E -A$7.034M; investments -A$3.790M; disposal proceeds +A$1.012M.

Financing: equity proceeds A$14.026M; transaction costs -A$1.036M.

Funding runway: estimated quarters of funding available at 30 June 2026 was 0.98.

Ratios (derived from tables above)

Ratios not meaningful:

  • ROIC: not meaningful (negative NOPAT, minimal invested debt).

  • Net debt/EBITDA: not meaningful (net cash, negative EBITDA).

  • Interest coverage: not meaningful (cash interest paid only about A$0.01–0.03M a year).

  • Asset turnover: 0 (no revenue).

  • Cash conversion cycle: not meaningful.

FY2026 ROE/ROA cannot be computed from primary data without year-end equity. Using H1 FY2026 equity as a proxy, FY2026 ROE is roughly -92% (derived, indicative only), driven by the write-down.

Commentary on trends, inflections and drivers

FY2022 — the balance sheet step-change. Total assets rose about tenfold (A$17.8M to A$174.2M) and contributed equity rose by about A$162M. The causes were the scrip acquisition of Minotaur, which consolidated 100% of Great White and Natural Nanotech and was recorded largely in project assets, plus about A$43M of financing inflows at peak market valuation. Cash peaked at A$32.9M.

FY2023 — peak spend. Free cash outflow peaked at -A$17.7M and R&D at A$2.84M as the DFS and pilot work were completed. This was the year of maximum technical de-risking.

FY2024–FY2025 — cash conservation. Andromeda cut burn, divested gold/copper (Moonta, Wudinna) and raised modest equity in FY2025 (about A$7.9M net financing). Cash fell to A$5.4M at 30 June 2024, a low point that forced the strategy towards external project finance. Merricks credit approval followed in June 2025.

FY2026 — inflection to distress. Three things happened together:

  • Andromeda raised about A$14M (including the A$13M placement) and committed most of it to early works and long-lead equipment, which is irreversible spending ahead of FID.

  • The planned Middle East cornerstone investment stalled after geopolitical events in the region.

  • The carrying value of GWP was written down by about A$99M.

Year-end cash of A$3.2M was below one quarter's outgoings, and the auditor flagged a going-concern material uncertainty.

Drivers. The financial trajectory is driven almost entirely by the timing and terms of project finance, not by operations.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Revenue

MetricFY2024FY2025FY2026

Great White Project revenue (AUD Mn)

000

HPA Project revenue (AUD Mn)

000

Total operating revenue (AUD Mn)

000

Results by Segment

MetricFY2024FY2025FY2026

Group operating income (AUD Mn)

-7.54-5.94-105.28

Group EBITDA (AUD Mn)

-6.45-5.62-6.18

Group Entities

EntityRoleOwnership

Andromeda Metals Limited

Listed parent

—

Andromeda Industrial Minerals Pty Ltd (AIM)

Holder of GWP mining lease ML 6532, MPLs 163/164, ELs 6588/6202/6426

100%

Andromeda Industrial Minerals Holdings Pty Ltd

Holding company

100%

Andromeda Industrial Minerals NZ Pty Ltd

Holder of Mt Hope EL 6286

100%

Eyre Kaolin Pty Ltd

51% participant in Eyre Kaolin JV (Peninsula Exploration Pty Ltd holds 49%)

100%

Peninsula Resources Pty Ltd

Legacy gold/copper tenement holder (small retained areas)

100%

Minotaur Exploration Pty Ltd

Former MEP, acquired 2022

100%

Natural Nanotech Pty Ltd

Halloysite nanotech R&D vehicle, consolidated after the Minotaur acquisition

—

Income Statement and Share Count (M)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue (AUD Mn)

00000

Gross profit (AUD Mn)

00000

SG&A (AUD Mn)

5.387.456.634.995.33

R&D expense (AUD Mn)

0.852.840.820.730.90

Operating income (AUD Mn)

-8.41-9.89-7.54-5.94-105.28

EBITDA (AUD Mn)

-7.88-8.94-6.45-5.62-6.18

D&A incl. impairment (AUD Mn)

0.520.941.090.3299.10

Pre-tax income (AUD Mn)

-8.73-11.01-8.03-6.04-105.03

Net income (AUD Mn)

-8.73-9.46-7.27-6.04-105.03

Weighted avg shares basic (M)

2,6623,1103,1103,4184,362

EPS basic (A$ cents, derived)

-0.33-0.30-0.23-0.18-2.41

EPS diluted (A$ cents, derived)

-0.33-0.30-0.23-0.18-2.41

Dividends per share (A$ cents)

00000

Balance Sheet and Share Count (M)

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (AUD Mn)

17.76174.22165.03158.07160.21

Cash & equivalents (AUD Mn)

4.9032.8515.305.447.14

PP&E incl. capitalised project assets (AUD Mn)

11.53139.50144.84149.94150.59

Total current assets (AUD Mn)

5.7634.3519.896.148.79

Total current liabilities (AUD Mn)

1.212.322.242.721.93

Total liabilities (AUD Mn)

1.273.032.873.192.27

Total debt, leases only (AUD Mn)

0.080.850.730.580.37

Short-term debt (AUD Mn)

0.060.170.200.220.21

Long-term debt (AUD Mn)

0.030.680.530.370.15

Net debt, negative = net cash (AUD Mn)

-4.82-32.01-14.57-4.85-6.78

Shareholders' equity (AUD Mn)

16.49171.19162.16154.88157.93

Goodwill & intangibles (AUD Mn)

00000

Working capital (AUD Mn)

4.5532.0317.653.436.86

Shares outstanding, period end (M)

2,1593,1063,1083,1083,813

Balance Sheet and Share Count (M) (31 Mar 2026–31 Dec 2025 (H1 FY2026))

Metric31 Dec 2025 (H1 FY2026)31 Mar 202630 Jun 2026

Cash (AUD Mn)

10.065.203.196

Total assets (AUD Mn)

71.66——

PP&E / project assets (AUD Mn)

54.35——

Equity (AUD Mn)

69.62——

Shares outstanding (M)

4,621

About 4621

About 4621 (about 5,136M after the September 2026 SPP, derived)

“—” = not publicly disclosed.

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (AUD Mn)

-5.14-9.13-5.05-4.77-5.04

Capex incl. capitalised E&E, derived (AUD Mn)

5.118.607.904.289.14

Free cash flow (AUD Mn)

-10.25-17.73-12.95-9.05-14.18

Investing cash flow (AUD Mn)

-9.83-8.19-4.56-1.40-11.69

Financing cash flow (AUD Mn)

42.92-0.22-0.257.8712.78

Equity raised, gross (AUD Mn)

—00—14.03

Dividends paid (AUD Mn)

00000

Share buybacks (AUD Mn)

00000

Net change in cash (AUD Mn)

27.95-17.55-9.861.71-3.95

“—” = not publicly disclosed.

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025

ROE (% on avg equity)

-9.3-5.7-4.6-3.9

ROA (% on avg assets)

-9.1-5.6-4.5-3.8

Current ratio (x)

14.88.92.34.6

Debt/equity, leases (x)

0.0050.0050.0040.002

Geographic Revenue

RegionFY2024FY2025FY2026

Australia revenue (AUD Mn)

000

Europe revenue (AUD Mn)

000

Asia-Pacific ex-Australia revenue (AUD Mn)

000

Americas revenue (AUD Mn)

000

Total revenue (AUD Mn)

000

Markets

MarketProductChannelBasis

Europe (ceramics)

Great White CRM™

Traxys Europe S.A.

Binding 5-year offtake, July 2024

Japan

Great White CRM™ / KCM™

Plantan Yamada Co Ltd

Offtake, June 2023

India and Middle East

Great White CRM™

Managed by Traxys

Per offtake terms

Concrete markets

Great White HRM™

Traxys plus conditional offtakes

Binding, with conditions on some

United States

4N HPA

Traxys North America

Non-binding HoA, August 2026

Share Price & Returns

Reference pointPrice (AUD)Source / date

MEP final trade (pre-merger entity)

0.205

InvestSMART, 10 March 2022

ADN 5-year high (approximate)

0.26

MarketScreener 5-year range

ADN at HPA Scoping Study

0.024

18 September 2025

ADN at start of 2026 (implied)

0.014

Derived from the YTD change of -57.14%

ADN at 31 March 2026 update

0.010

InvestSMART

ADN SPP issue price

0.0059

4 September 2026

ADN latest

0.006

9 October 2026

Valuation Multiples

MultipleADNComment

Market cap

About A$30.8M

MarketScreener (October 2026)

Enterprise value

About A$25M (derived: market cap less about A$6M pro-forma cash after the SPP, no debt)

MarketScreener shows A$105M, apparently on forecast net debt (Merricks); treat with caution

P/E

N/M (loss-making)

—

EV/EBITDA

N/M

—

EV/Sales

N/M

MarketScreener's FY2028E EV/Sales of 5.74x relies on a single forecast

P/B

About 0.35 (Eulerpool, August 2026); about 0.44 on 31 December 2025 equity (derived)

Market values the company well below post-impairment book

Capital Markets

ItemDetail

Dividend history / policy

None paid; no policy (pre-revenue)

Credit ratings (Moody's / S&P / Fitch)

Not rated

Debt maturity profile

No borrowings. Leases about A$0.26M (31 December 2025). Merricks A$75M facility undrawn and unexecuted

Listed options

About 293.5M, exercise A$0.0195, expiring 2 July 2027 (deeply out of the money)

Analyst Conclusions

Management guidance

  • About A$40M of equity is needed, alongside the A$75M Merricks debt, to reach FID on Stage 1A+.

  • Continued engagement with a Middle East cornerstone investor, plus evaluation of "funding, strategic and corporate opportunities".

  • HPA commercial samples in H2 2026; a PFS subject to funding.

  • Operating cash outflows expected to fall after early works and cost savings (Appendix 5B commentary, 31 July 2026).

Consensus

There is no reliable consensus. The stale aggregator forecast of a A$34M profit in FY2027 is not credible without FID.

Bull case

  1. The cornerstone deal closes. Due diligence is complete and terms had reached final stages before the geopolitical delay. Closing the about A$40M would unlock the A$75M Merricks facility and fully fund Stage 1A+, with permits, offtake and long-lead equipment already in place.

  2. HPA re-rates the company. Pilot-scale 4N HPA (99.9986%), a US pathway through Traxys and Project Vault, and a scoping NPV of about A$1.48bn could attract strategic capital disproportionate to the about A$31M market cap.

  3. Asset value is well below replacement cost. P/B is about 0.35–0.44 even after a A$99M write-down, the early-works spend is sunk, and R&D refunds (43.5% on about A$26M) reduce net capex.

Bear case

  1. Funding gap versus market cap. About A$40M of equity against about A$31M market cap means any equity solution is likely to be highly dilutive or to sit at asset level, capturing value away from ordinary shareholders.

  2. Liquidity is thin. Less than two quarters of runway even after the A$3.04M SPP, plus an auditor going-concern flag. A failed process could force a distressed sale or recapitalisation.

  3. HPA is early stage. HPA remains pre-PFS, needs about A$155M of capex itself, and faces entrenched incumbents and better-funded Australian peers. Kaolin offtake pricing is only fixed for two years.

Key catalysts and monitorables (next 12 months)

  1. September 2026 quarterly report (due about 29 October 2026): cash, burn and status of the cornerstone process.

  2. Execution or failure of the cornerstone equity agreement; Merricks binding documentation and first drawdown.

  3. Appointment of a permanent CEO.

  4. HPA customer sample feedback and any binding HPA offtake (conversion of the Traxys North America HoA).

  5. Commencement of an HPA PFS and any government or critical-minerals funding (Australian or US EXIM / Project Vault).

  6. Further equity raises: pricing and dilution.

  7. Any corporate transaction (merger, asset sale or strategic partner) flagged under "corporate opportunities".

  8. Status of the long-lead equipment and Traxys offtake terms if FID slips into 2027.

Analyst verdict

Minotaur Exploration's legacy now lives in two places. The copper-gold half sits inside AIC Mines. The kaolin half, Minotaur's founding 25% stake in Great White, sits inside Andromeda Metals.

For anyone tracking the MEP line, Andromeda is the relevant security, and its 2022–2026 record has been value-destructive. The ADN shares issued for each MEP share are worth well under a cent today, against A$0.205 at delisting.

Operationally, Andromeda has done most of what a developer can do without capital. Great White is permitted, engineered and offtaken. Early works are complete, and key equipment is in Australia. Debt is credit-approved. The HPA flowsheet, potentially the more valuable idea, has crossed from laboratory to continuous pilot at 4N purity and has a credible US route to market through Traxys.

The problem is entirely financial. With A$3.2M of cash at June 2026, topped up by A$3.0M in September, a going-concern flag and an about A$40M equity gap larger than its market value, Andromeda's negotiating position with capital providers is weak. The roughly A$99M FY2026 write-down shows the board itself accepting a lower carrying value. The leadership structure, with an acting CEO since 2024 and a new CFO, adds execution risk exactly when credibility with investors matters most.

Our assessment is that ADN is a binary, special-situation equity. If an asset-level cornerstone deal closes on reasonable terms, the stock could re-rate sharply given the low P/B and the HPA optionality. However, the most probable outcomes are heavy dilution or a value-sharing structure at project level, and the downside includes recapitalisation if funding fails before cash runs out.

Monitoring priority: the cornerstone outcome, cash runway and the CEO appointment. Until FID is achieved, we view the risk/reward as speculative, with downside skew for existing shareholders.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure / appointmentBackground (as disclosed)

Sarah Clarke

Acting Chief Executive Officer (also General Counsel and Company Secretary)

General Counsel/CoSec from 9 January 2023; Acting CEO since 11 September 2024

LLB (Hons), BSc, Grad Cert (Applied Finance and Investment)

Keith Pollocks

Chief Financial Officer

Appointed July 2026 (announced 13 July 2026)

More than 30 years in senior finance roles across resources, mining, infrastructure, banking and industrials

Joseph (Joe) Ranford

Chief Operating Officer

Since about April 2020 (MarketScreener)

Not detailed in sources reviewed

Patrick Sinclair

Manager, Investor Relations & Corporate Affairs

——

“—” = not publicly disclosed.

Board of Directors

NameRoleIndependenceNotes

Sue-Ann Higgins

Executive Chair

Not independent (executive)

Executive Chair since 11 September 2024; accepting reduced fees

Mick Wilkes

Non-Executive Director

Not stated

Assists with GWP financing; waived all director fees until GWP is fully financed

Miguel J. Galindo

Non-Executive Director (effective 16 January 2025)

Not stated (prior consulting/marketing role for ADN)

Chemical engineer; President of the Spanish Glass & Ceramics Society (SECV); NED at Port-Sur (Port of Castellón); oversees European market relations

Jean-Dominique Sorel

Non-Executive Director

Not stated

—

Directors' Remuneration

RoleTotal remuneration (A$, FY2025)Holding (%)

Executive Chair (Sue-Ann Higgins)

149,6900.030

Independent NED

16,6700.082

NED

99,2800.037

NED

177,200—

“—” = not publicly disclosed.

Major Shareholders

Holder categoryDetail

Top 10 institutional holders

Not publicly disclosed in sources reviewed. No substantial-holder (>5%) notices were identified; see the FY2026 Annual Report top-20 schedule

ETF ownership

None (InvestSMART)

Free float

About 88–99% (MarketScreener, varying by date)

Insider ownership

Board holdings individually below 0.1% each (Simply Wall St)

Retail base

Large. 342 holders participated in the September 2026 SPP

Competitive Landscape

Key Competitors

CompetitorSegment overlapScale / positioning (qualitative)Relative to ADN

Imerys (France)

Kaolin, ceramics minerals

Global industrial-minerals leader with multi-billion-euro revenue and integrated mines worldwide

Incumbent supplier to ADN's target ceramics customers; vastly larger

Sibelco (Belgium)

Kaolin, ball clay, silica

Global, private, multi-billion-euro

Incumbent in European ceramics

Kaolin AD (Bulgaria)

Kaolin, quartz sand

Regional European producer

Direct European ceramics competitor

Thiele Kaolin / KaMin-CADAM (US/Brazil)

Kaolin (paper, coatings, ceramics)

Major Americas producers

Indirect (different end-markets)

Suvo Strategic Minerals (ASX: SUV)

Kaolin (Pittong, Victoria)

Small Australian producer

Closest listed Australian kaolin peer

Sumitomo Chemical (Japan)

HPA

Global HPA leader (alkoxide route)

Incumbent in 4N/5N HPA

Sasol (South Africa / Germany)

HPA

Large established HPA producer

Incumbent

Baikowski (France)

HPA / specialty alumina

Specialist producer

Incumbent in high-spec niches

Alpha HPA (ASX: A4N)

HPA (Gladstone, Qld)

Australian HPA developer/producer with government support

Most direct Australian HPA competitor; further advanced

FYI Resources (ASX: FYI)

HPA (WA, kaolin feed)

Australian HPA developer

Similar kaolin-to-HPA concept

Chinese HPA producers (various)

HPA

Dominant volume suppliers

Price-setters; geopolitical substitution creates an opening for ADN

Competitor Detail

MetricAndromeda (ADN)

Revenue

Nil (FY2026)

Revenue growth

N/M

EBITDA margin

N/M (EBITDA -A$6.2M)

R&D intensity

N/M (R&D A$0.9M)

Stage

Pre-FID developer

Recent Developments

--

Company Snapshot

2001

Founded

Adelaide, Australia

Headquarters

SWOT Analysis

Strengths

  • Development-ready. Early works are complete: access, plant pad, stormwater pond, geotechnical and grade-control drilling (ASX, 15 April 2026).
  • Fully permitted. ML 6532 and MPLs 163/164 granted, and the environmental bond lodged (24 November 2025).
  • Offtake. 100% offtake coverage for Stage 1A+ through the binding Traxys agreement (July 2024).
  • Debt credit-approved. The A$75M Merricks facility includes a cost-overrun tranche (4 June 2025).
  • HPA validated at pilot scale. 99.9986% purity, independently verified by EAG/Eurofins (24 August 2026).
  • Non-dilutive funding. About A$26M of Stage 1A+ spend is eligible for a 43.5% R&D refund under an AusIndustry Advance Finding; A$1.66M was received in May 2026.

Weaknesses

  • Liquidity. Cash of A$3.196M and 0.98 quarters of funding at 30 June 2026 (Appendix 5B).
  • Going concern. The auditor's going-concern material uncertainty on the FY2026 accounts (28 September 2026).
  • Write-down. About A$99M written off project carrying value in FY2026; equity fell from A$157.9M to A$69.6M by 31 December 2025 (aggregator).
  • Leadership. No permanent CEO since September 2024, and CFO turnover in mid-2026.
  • Dilution. Shares outstanding rose from about 3.1bn (FY2024) to about 5.1bn after the September 2026 SPP; the latest raise was priced at A$0.0059.
  • No revenue history. Five consecutive years of nil operating revenue, with cumulative net losses of about A$136M from FY2022 to FY2026 (derived).

Opportunities

  • HPA scale. Scoping NPV10 of about A$1.48bn and average EBITDA of about A$247M per year at 10 ktpa (September 2025).
  • US market access. The Traxys North America HoA aligns HPA with US Project Vault (August 2026).
  • Co-products. Amorphous silica and gallium could add value (June 2026 update).
  • Asset-level investment. A Middle East cornerstone investment covering GWP and HPA has completed due diligence.
  • Kaolin expansion. Stages 1B and 2 (+230 ktpa) and the Eyre Kaolin JV (option to 80%) offer growth.
  • Concrete decarbonisation. HRM™ demand linked to concrete decarbonisation.

Threats

  • Geopolitics. Middle East events have already delayed the cornerstone process and could affect diesel costs (company caveat, July 2026).
  • Heavy dilution or restructuring. The about A$40M equity need exceeds the about A$31M market cap.
  • HPA competition. Chinese HPA supply and better-funded Australian peers such as Alpha HPA.
  • Offtake erosion. Delays risk eroding offtaker patience and the Merricks credit approval, which remains subject to finalising the equity.
  • Pricing. Kaolin price negotiation from year 3 of the offtake.
  • Capex inflation. The cost-control gains from early works could reverse.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
29 Apr 2025Quarterly report: progress on Stage 1A+ funding and operationsFunding narrative established
1 May 2025Lab-scale 4N HPA (99.9985%) from Great White kaolinLaunches the HPA strategy
4 Jun 2025Merricks Capital credit-approves A$75M debt facilityMajor de-risking of the debt component
2025 (mid)About A$5M placement at A$0.013Funds early works and HPA scoping
Sep 2025FY2025 Annual Report released (market cap then about A$76M per TipRanks)Baseline before the FY2026 deterioration
18 Sep 2025HPA Scoping Study: 10 ktpa, NPV10 about A$1.48bn, average EBITDA about A$247MShares rose about 20% to A$0.024
Q1 FY2026A$13M placement completedPeak FY2026 funding
30 Oct 2025September 2025 quarterly reportConfirms the placement and equity discussions
24 Nov 2025GWP environmental bond lodged; early works commenceFirst on-site construction-type activity
5 Dec 2025Listed option offer prospectusShareholder sweetener
10 Dec 2025AGM resultsGovernance
11 Dec 2025About 293.5M listed options (A$0.0195, expiring July 2027) quotedPotential future funding (out of the money at the current price)
24 Dec 2025Early works progress update (access track, geotechnical drilling complete)Execution
5 Jan 2026Cessation of securities noticeCapital structure
21 Jan 2026Application for quotation of securitiesCapital structure
30 Jan 2026December 2025 quarterly reportContinued early works
16 Mar 2026Half-year report to 31 December 2025 (project asset write-down of about A$99M implied by aggregator data)Material negative revaluation
31 Mar 2026Company update: cornerstone equity delayed by Middle East geopolitics; about A$3M cost savings; HPA PFS planned for H2 2026 subject to fundingKey negative inflection. Shares fell about 25–30% in the following weeks
2 Apr 202668,572 shares issued on option conversionMinor
15 Apr 2026Early works completed; equity balance for FID cut to about A$40MPartial offset to funding risk
29 Apr 2026March 2026 quarterly reportBulk earthworks and grade-control drilling
30 Apr 2026CFO Pascal Alexander-Bossy resigns (effective 26 June 2026); CEO search "well progressed"Leadership churn
5 May 2026A$1.66M R&D tax refund receivedNon-dilutive cash
22 Jun 2026HPA Project update: pilot commissioning commenced; gallium identified as a potential co-productTechnical progress
26 Jun 20264.84M performance rights lapseIncentive reset
13 Jul 2026Keith Pollocks appointed CFO; company update presentationLeadership
29 Jul 2026HPA pilot plant commissioning completed; optimisation underwayTechnical milestone
31 Jul 2026June 2026 quarterly report: cash A$3.196M; 0.98 quarters of fundingLiquidity warning
12 Aug 2026SPP launched to raise about A$3MBridge funding
19 Aug 2026Strategic non-binding HPA Supply HoA with Traxys North America (US)Commercial validation of HPA
24 Aug 20264N HPA (99.9986%) at continuous pilot scale; independently verifiedStrongest technical milestone to date
4 Sep 2026SPP and placement raise A$3,044,576 at A$0.0059 (342 SPP participants)Extends runway by roughly a quarter
28 Sep 2026FY2026 accounts: auditor raises going-concern material uncertaintyFormal distress signal
29 Sep 2026FY2026 full-year results / annual report (net loss about A$105M, aggregator)Confirms the scale of the write-down
Late Oct 2026 (expected, about 29 October)September 2026 quarterly report dueNext disclosure catalyst

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

1 chart
Results by Segment: Group operating income fell from AUD -7.5 Mn in FY2024 to AUD -105.3 Mn in FY2026.
Minotaur Exploration Limited — Results by Segment
Series (AUD Mn)FY2024FY2025FY2026
Group operating income-7.5-5.9-105.3
Group EBITDA-6.5-5.6-6.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. ADN Quarterly Activity Report, June 2026 (31 July 2026)
  2. ADN Quarterly Activity Report, March 2026 (29 April 2026)
  3. ADN Executive Management Update (30 April 2026)
  4. ADN SPP Results (4 September 2026)
  5. ADN 4N HPA at Continuous Pilot Scale (24 August 2026)
  6. ADN Board and Executive Changes (11 September 2024)
  7. ADN Half-Year Report H1 FY2025
  8. ADN Half-Year Report H1 FY2024
  9. Andromeda / Minotaur combination announcement (10 November 2021)
  10. Demetallica FY2022 Annual Report
  11. ADN / MEP Rover JV announcement (16 April 2018)
  12. Traxys HPA HoA announcement (26 August 2026)
  13. Invest SA, Great White Project page: Press and aggregators
  14. InvestSMART announcement summaries (ADN and MEP)
  15. Mining Weekly / Engineering News (2021–22 deal coverage)
  16. InDaily (11 November 2021)
  17. Mining Technology (Merricks facility: AIC–Demetallica)
  18. Stockhead, Kalkine, AL Circle, mining.com.au (HPA)
  19. Australian Mining (Traxys offtake)
  20. S&P Global Market Intelligence via StockAnalysis (financials, updated 29 September 2026)
  21. TipRanks, Barchart, Kalkine Media, MarketScreener / Zonebourse, Simply Wall St, Eulerpool, Morningstar
  22. HopgoodGanim (AIC–Demetallica)
  23. Smallcaps.com.au and Resources Roadhouse (Minotaur history)

ASX announcements and company documents

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.